Details van artikel 122 van 459 gevonden artikelen
163P Are clinical factors useful for identifying primary progressors (PP) in patients (pts) with hepatocellular carcinoma (HCC) undergoing first-line treatment with atezolizumab plus bevacizumab (AB)? Analysis from the Italian ARTE database
Titel:
163P Are clinical factors useful for identifying primary progressors (PP) in patients (pts) with hepatocellular carcinoma (HCC) undergoing first-line treatment with atezolizumab plus bevacizumab (AB)? Analysis from the Italian ARTE database
Auteur:
Cesario, S. Vivaldi, C. Tovoli, F. Iavarone, M.A. Cabibbo, G. Dalbeni, A. Salani, F. Marra, F. Ponziani, F.R. Soldà , C. Palloni, A. Svegliati-Baroni, G. Pressiani, T. Federico, P. Foschi, F.G. Fornaro, L. Piscaglia, F. Masi, G.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 36 () nr. S1 pagina's S70-S71
Jaar:
2025
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 122 van 459 gevonden artikelen